Försti Asta, Jin Qianren, Altieri Andrea, Johansson Robert, Wagner Kerstin, Enquist Kerstin, Grzybowska Ewa, Pamula Jolanta, Pekala Wioletta, Hallmans Göran, Lenner Per, Hemminki Kari
Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Breast Cancer Res Treat. 2007 Jan;101(1):83-93. doi: 10.1007/s10549-006-9265-1. Epub 2006 Jun 29.
Angiogenesis is an important step in the development of cancer. Vascular endothelial growth factor is a major regulator of breast cancer angiogenesis, the effects of which are transmitted through the kinase domain receptor (KDR). Up-regulation of KDR by periostin (POSTN) induces angiogenesis. We screened the KDR and the POSTN genes for published single nucleotide polymorphisms (SNPs) and chose two SNPs in each gene for further analyses. We carried out a case-control study consisting of 412 familial and 912 unselected breast cancer cases together with ethnically and geographically selected controls. Genotype, haplotype and genotype combination analyses were carried out to evaluate their effect on susceptibility to and prognosis of breast cancer. A haplotype in the POSTN gene was associated with an increased risk even after correction for multiple comparisons. Nominal associations between the SNPs and prognostic indicators were also observed. Tumors of the KDR 472His allele carriers were less often progesterone receptor negative according to both genotype and haplotype analyses (OR 0.61, 95%CI 0.40-0.92 and OR 0.60, 95%CI 0.40-0.91, respectively). The POSTN -33G allele carriers had more often high grade and estrogen receptor negative tumors (OR 1.75, 95%CI 1.02-3.01 and OR 1.70, 95%CI 1.04-2.78, respectively). The overall and cancer specific survival after 15 years of follow-up was more than 75%, and it did not depend on the genotype. Although a major effect of the SNPs in the KDR and the POSTN genes on breast cancer susceptibility and prognosis was excluded, the effect of the POSTN C-33G SNP on prognosis needs further characterization.
血管生成是癌症发展过程中的重要一步。血管内皮生长因子是乳腺癌血管生成的主要调节因子,其作用通过激酶结构域受体(KDR)传递。骨膜蛋白(POSTN)上调KDR可诱导血管生成。我们筛查了KDR和POSTN基因已发表的单核苷酸多态性(SNP),并在每个基因中选择了两个SNP进行进一步分析。我们进行了一项病例对照研究,包括412例家族性乳腺癌病例和912例未经过选择的乳腺癌病例,以及按种族和地理因素选择的对照。进行了基因型、单倍型和基因型组合分析,以评估它们对乳腺癌易感性和预后的影响。即使在进行多重比较校正后,POSTN基因中的一种单倍型仍与风险增加相关。还观察到SNP与预后指标之间的名义关联。根据基因型和单倍型分析,KDR 472His等位基因携带者的肿瘤较少为孕激素受体阴性(分别为OR 0.61,95%CI 0.40 - 0.92和OR 0.60,95%CI 0.40 - 0.91)。POSTN -33G等位基因携带者的肿瘤更常为高级别且雌激素受体阴性(分别为OR 1.75,95%CI 1.02 - 3.01和OR 1.70,95%CI 1.04 - 2.78)。随访15年后的总生存率和癌症特异性生存率均超过75%,且不依赖于基因型。虽然排除了KDR和POSTN基因中的SNP对乳腺癌易感性和预后的主要影响,但POSTN C-33G SNP对预后的影响仍需进一步明确。